Coronavirus disease 2019 (COVID-19) which is caused by the virus SARS-CoV-2 has resulted in an ongoing global pandemic. It is unclear whether the relatively low number of reported cases of COVID-19 in people with CF (pwCF) is due to enhanced infection prevention practices or whether pwCF have protective genetic/immune factors. This study aims to prospectively assess the proportion of pwCF, including both adults and children with CF who have evidence of SARS-CoV-2 antibodies over a two-year period. This study will also examine whether pwCF who have antibodies for SARS-CoV-2 have a different clinical presentation and what impact this has on...
Over the course of this year’s CF Week – taking place from 13 to 19 June – we will be sharing stories from across the CF community about life with CF: the ups, the downs and everything in between. Here, Dom, Helpline Officer at the Trust, tells us about the impact CF has on his mental health and how he manages these challenges.
“The work carried out by Cystic Fibrosis Trust is invaluable” Our supporter and volunteer Lian, whose son Henry has CF, shares why she’s uniting with us for Wear Yellow Day on Friday 17 June. Will you join her and help ensure everybody with CF can live without limits?
Today we're celebrating International Clinical Trials Day! To mark the date this year, we hear from members of the CF community about their clinical trials experiences.
On 28 April, the Health and Care Bill was granted Royal Assent, enacting into law what the Government has described as ’the most significant health legislation in a decade’. But what does this mean for the Trust and our community? Here's a quick explainer on what matters to us most in this Act
